• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血栓形成并发症孕妇凝血系统主要指标的变化]

[The changes of the main indices of the blood coagulation system in pregnant women with thrombotic complications].

作者信息

Shakhbazov Sh G

出版信息

Klin Khir. 2009 Apr(4):47-50.

PMID:19957736
Abstract

The dynamics of some parameters of hemostasis (vascular-thrombocytic, coagulation and anticoagulation chains) in 303 pregnant women while the thrombotic complications occurrence and in 76 healthy pregnant women was studied up. The most pronounced pathological changes were revealed in the II and III trimesters of pregnancy in women, suffering thrombotic complications. A change of the thrombocytes form as a primary answer was noted while studying their aggregation capacity. A content of thrombin-antithrombin complex and a fibrin products of elimination (D-dimer) have had exceeded such in a control group, trusting the fibrinolysis and coagulation processes activation present.

摘要

对303例有血栓形成并发症的孕妇以及76例健康孕妇止血的一些参数(血管 - 血小板、凝血和抗凝链)动态变化进行了研究。在发生血栓形成并发症的孕妇中,妊娠中晚期出现了最明显的病理变化。在研究血小板聚集能力时,发现血小板形态改变是首要反应。凝血酶 - 抗凝血酶复合物含量和纤维蛋白降解产物(D - 二聚体)超过了对照组,表明存在纤溶和凝血过程的激活。

相似文献

1
[The changes of the main indices of the blood coagulation system in pregnant women with thrombotic complications].[血栓形成并发症孕妇凝血系统主要指标的变化]
Klin Khir. 2009 Apr(4):47-50.
2
Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.凝血激活标志物与孕妇血栓形成的临床风险无关。
Am J Obstet Gynecol. 2001 Feb;184(3):382-9. doi: 10.1067/mob.2001.109397.
3
Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.正常孕妇体内的纤维蛋白单体复合物:一种潜在的妊娠血栓形成标志物。
Ann Clin Biochem. 2007 Sep;44(Pt 5):449-54. doi: 10.1258/000456307781646076.
4
[Hemostasis in pregnant women with varicose veins].[患有静脉曲张的孕妇的止血情况]
Akush Ginekol (Mosk). 1989 Aug(8):67-8.
5
Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.体外膜肺氧合中凝血和纤维蛋白溶解激活标志物的年龄差异。
Pediatr Crit Care Med. 2014 Jun;15(5):e198-205. doi: 10.1097/PCC.0000000000000107.
6
[Venous thrombotic complications in pregnancy: way of prophylaxis and therapy].
Georgian Med News. 2009 May(170):19-24.
7
Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.全球血栓形成试验(GTT)可以检测止血的主要决定因素,包括血小板反应性、内源性纤维蛋白溶解和凝血酶生成潜力。
Thromb Res. 2014 May;133(5):919-26. doi: 10.1016/j.thromres.2014.02.018. Epub 2014 Feb 25.
8
[Pre- and postpartum hemostatic characteristics in pregnancy-related hypertension and pre-eclampsia in comparison with normotensive pregnancies].[与血压正常的妊娠相比,妊娠相关高血压和子痫前期的产前和产后止血特征]
Z Geburtshilfe Neonatol. 1996 May-Jun;200(3):104-8.
9
[Clinical and rheological efficacy of troxerutin in obstetric gynecology].曲克芦丁在妇产科的临床及流变学疗效
Rev Fr Gynecol Obstet. 1991 Feb 25;86(2 Pt 2):209-12.
10
Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.纤维蛋白溶解与凝血抑制的病理生理学及临床方面。特别针对口服避孕药的女性和特定血栓易患人群的实验与临床研究。
Dan Med Bull. 1988 Feb;35(1):1-33.

引用本文的文献

1
Reference Intervals of Routine Coagulation Assays During the Pregnancy and Puerperium Period.孕期及产褥期常规凝血检测的参考区间
J Clin Lab Anal. 2016 Nov;30(6):912-917. doi: 10.1002/jcla.21956. Epub 2016 Apr 7.